Neuroprotective effects of erythropoietin on Alzheimer’s dementia model in rats
Article Properties
-
DOI (url)
-
Publication Date2017/03/01
-
Indian UGC (journal)
-
Citations26
-
Betul Cevik
-
Volkan Solmaz
-
Gurkan Yigitturk
-
Turker Cavusoğlu
-
Gonul Peker
-
Oytun Erbas
Cite
Cevik, Betul, et al. “Neuroprotective Effects of Erythropoietin on Alzheimer’s Dementia Model in Rats”. Advances in Clinical and Experimental Medicine, vol. 26, no. 1, 2017, pp. 23-29, https://doi.org/10.17219/acem/61044.
Cevik, B., Solmaz, V., Yigitturk, G., Cavusoğlu, T., Peker, G., & Erbas, O. (2017). Neuroprotective effects of erythropoietin
on Alzheimer’s dementia model in rats. Advances in Clinical and Experimental Medicine, 26(1), 23-29. https://doi.org/10.17219/acem/61044
Cevik B, Solmaz V, Yigitturk G, Cavusoğlu T, Peker G, Erbas O. Neuroprotective effects of erythropoietin
on Alzheimer’s dementia model in rats. Advances in Clinical and Experimental Medicine. 2017;26(1):23-9.
Journal Categories
Medicine
Medicine
Medicine (General)
Science
Microbiology
You May Also Like
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease | Ageing Research Reviews |
| 2024 | |
| Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review | Pharmacological Research |
| 2024 | |
| Erythropoietin ameliorates cognitive deficits by improving hippocampal and synaptic damage in streptozotocin-induced diabetic mice | Cellular Signalling |
| 4 | 2023 |
Pathogenesis of Chronic Kidney Disease Is Closely Bound up with Alzheimer’s Disease, Especially via the Renin-Angiotensin System | Journal of Clinical Medicine |
| 2 | 2023 |
The effects of postnatal erythropoietin and nano‐erythropoietin on behavioral alterations by mediating K‐Cl co‐transporter 2 in the valproic acid‐induced rat model of autism | Developmental Psychobiology |
| 5 | 2022 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 9
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks and was published in 2018. The most recent citation comes from a 2024 study titled Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review. This article reached its peak citation in 2019, with 6 citations. It has been cited in 26 different journals, 26% of which are open access. Among related journals, the Pharmacological Research cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.